Hyperuricemia and Progression of CKD in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort Study
Kyle E. Rodenbach,Michael F. Schneider,Susan L. Furth,Marva M. Moxey-Mims,Mark M. Mitsnefes,Donald J. Weaver,Bradley A. Warady,George J. Schwartz
DOI: https://doi.org/10.1053/j.ajkd.2015.06.015
IF: 11.072
2015-12-01
American Journal of Kidney Diseases
Abstract:BACKGROUND: <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Hyperuricemia is associated with essential hypertension in children. No previous studies have evaluated the effect of hyperuricemia on progression of chronic kidney disease (CKD) in children.</AbstractText>STUDY DESIGN: <AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Prospective observational cohort study.</AbstractText>SETTING & PARTICIPANTS: <AbstractText Label="SETTING &amp; PARTICIPANTS" NlmCategory="METHODS">Children and adolescents (n=678 cross-sectional; n=627 longitudinal) with a median age of 12.3 (IQR, 8.6-15.6) years enrolled at 52 North American sites of the CKiD (CKD in Children) Study.</AbstractText>PREDICTOR: <AbstractText Label="PREDICTOR" NlmCategory="METHODS">Serum uric acid level (&lt;5.5, 5.5-7.5, and &gt;7.5mg/dL).</AbstractText>OUTCOMES: <AbstractText Label="OUTCOMES" NlmCategory="RESULTS">Composite end point of either &gt;30% decline in glomerular filtration rate (GFR) or initiation of renal replacement therapy.</AbstractText>MEASUREMENTS: <AbstractText Label="MEASUREMENTS" NlmCategory="METHODS">Age, sex, race, blood pressure status, GFR, CKD cause, urine protein-creatinine ratio (&lt;0.5, 0.5-&lt;2.0, and ≥2.0mg/mg), age- and sex-specific body mass index &gt; 95th percentile, use of diuretics, and serum uric acid level.</AbstractText>RESULTS: <AbstractText Label="RESULTS" NlmCategory="RESULTS">Older age, male sex, lower GFR, and body mass index &gt; 95th percentile were associated with higher uric acid levels. 162, 294, and 171 participants had initial uric acid levels &lt; 5.5, 5.5 to 7.5, or &gt;7.5 mg/dL, respectively. We observed 225 instances of the composite end point over 5 years. In a multivariable parametric time-to-event analysis, compared with participants with initial uric acid levels &lt; 5.5mg/dL, those with uric acid levels of 5.5 to 7.5 or &gt;7.5mg/dL had 17% shorter (relative time, 0.83; 95% CI, 0.62-1.11) or 38% shorter (relative time, 0.62; 95% CI, 0.45-0.85) times to event, respectively. Hypertension, lower GFR, glomerular CKD cause, and elevated urine protein-creatinine ratio were also associated with faster times to the composite end point.</AbstractText>LIMITATIONS: <AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">The study lacked sufficient data to examine how use of specific medications might influence serum uric acid levels and CKD progression.</AbstractText>CONCLUSIONS: <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Hyperuricemia is a previously undescribed independent risk factor for faster progression of CKD in children and adolescents. It is possible that treatment of children and adolescents with CKD with urate-lowering therapy could slow disease progression.</AbstractText>